Pursuant to the requirement of Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Gujarat Terce Laboratories has informed that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, 28th October, 2024, to consider and approve the Unaudited Financial Results of the Company for the quarter ended on 30th September, 2024 (the ‘Results’). Further, in accordance with the Company's Code of Conduct for Prevention of Insider Trading, the Company has earlier intimated its designated persons and to the stock exchanges regarding the closure of the Trading Window for trading in the Company's equity shares from 1st October, 2024 till the expiry of 48 hours from the date the Results are declared and made public. Thus, the Trading Window Closure Period for trading in the Company's equity shares shall end 48 hours after the Results of the Company are declared and made public on 28th October, 2024.
The above information is a part of company’s filings submitted to BSE.